{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:28:49Z","timestamp":1793946529636,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025A1515010469"],"award-info":[{"award-number":["2025A1515010469"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["2025A03J3979"],"award-info":[{"award-number":["2025A03J3979"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018634","name":"State Key Laboratory of Ophthalmology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.exer.2026.111041","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:52:27Z","timestamp":1777359147000},"page":"111041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["In vivo engineering of immunosuppressive T cells to treat ocular autoimmune diseases"],"prefix":"10.1016","volume":"268","author":[{"given":"Dongliang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Feng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianchai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2026.111041_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-1-60761-720-4_22","article-title":"Rodent models of experimental autoimmune uveitis","volume":"900","author":"Agarwal","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.exer.2026.111041_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101380","article-title":"Immunomodulatory therapy in non-infectious uveitis: current landscape, gaps, and future directions","volume":"108","author":"Agrawal","year":"2025","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2026.111041_bib3","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/sj.mt.6300281","article-title":"Stable gene transfer to muscle using non-integrating lentiviral vectors","volume":"15","author":"Apolonia","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2026.111041_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2026.111041_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/imr.12029","article-title":"Metabolic control of the Treg\/Th17 axis","volume":"252","author":"Barbi","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.exer.2026.111041_bib6","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 european group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.exer.2026.111041_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108409","article-title":"CAR treg: a new approach in the treatment of autoimmune diseases","volume":"102","author":"Beheshti","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.exer.2026.111041_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1146\/annurev-immunol-020711-075043","article-title":"Induced CD4+Foxp3+ regulatory T cells in immune tolerance","volume":"30","author":"Bilate","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.exer.2026.111041_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2019.02.006","article-title":"AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing treg cells","volume":"100","author":"Bing","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.exer.2026.111041_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/erm.12.133","article-title":"Assessment of regulatory T-cell function in forthcoming clinical trials of cell therapy","volume":"13","author":"Canavan","year":"2013","journal-title":"Expert Rev. Mol. Diagn"},{"key":"10.1016\/j.exer.2026.111041_bib11","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/eji.202048616","article-title":"Functionally distinct IFN-\u03b3(+) IL-17A(+) Th cells in experimental autoimmune uveitis: T-Cell heterogeneity, migration, and steroid response","volume":"50","author":"Chen","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.exer.2026.111041_bib12","first-page":"65","article-title":"CD4+ T cells from behcet patients produce high levels of IL-17","volume":"26","author":"Chi","year":"2011","journal-title":"Eye Sci."},{"key":"10.1016\/j.exer.2026.111041_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-61737-979-6_2","article-title":"In vitro treg suppression assays","volume":"707","author":"Collison","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.exer.2026.111041_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1062045","article-title":"A review of TSHR- and IGF-1R-related pathogenesis and treatment of graves' orbitopathy","volume":"14","author":"Cui","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2026.111041_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2026.111041_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.648732","article-title":"Mechanisms that underly T cell immunity in graves' orbitopathy","volume":"12","author":"Fang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2026.111041_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1479","article-title":"Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non-infectious uveitis","volume":"12","author":"Ferreira","year":"2023","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.exer.2026.111041_bib18","first-page":"5702","article-title":"Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectors","volume":"4","author":"Frank","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.exer.2026.111041_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105834","article-title":"Viral and non-viral vectors in gene therapy: current state and clinical perspectives","volume":"118","author":"Geng","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.exer.2026.111041_bib20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/mt.2010.50","article-title":"Lymphomagenesis in SCID-X1 mice following lentivirus-mediated phenotype correction independent of insertional mutagenesis and gammac overexpression","volume":"18","author":"Ginn","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2026.111041_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-024-03123-6","article-title":"Decoding Behcet's uveitis: an In-depth review of pathogenesis and therapeutic advances","volume":"21","author":"Guan","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2026.111041_bib22","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","article-title":"In vivo human T cell engineering with enveloped delivery vehicles","volume":"42","author":"Hamilton","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.exer.2026.111041_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41433-018-0279-9","article-title":"The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy","volume":"33","author":"Huang","year":"2019","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.exer.2026.111041_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.preteyeres.2008.07.001","article-title":"The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis","volume":"27","author":"Kerr","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2026.111041_bib25","article-title":"A T-cell engager platform induces deep plasma cell depletion in autoimmune dry eye","author":"Ling","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.exer.2026.111041_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.coi.2010.11.010","article-title":"Becoming self-aware: the thymic education of regulatory T cells","volume":"23","author":"Lio","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.exer.2026.111041_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.exer.2026.111041_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.exer.2026.111041_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jama.2025.4358","article-title":"Uveitis in adults: a review","volume":"334","author":"Maghsoudlou","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.exer.2026.111041_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10238-025-01565-7","article-title":"Role of CD4(+) T cell-derived cytokines in the pathogenesis of uveitis","volume":"25","author":"Meng","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.exer.2026.111041_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"T(reg) cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.exer.2026.111041_bib32","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.survophthal.2020.01.002","article-title":"Steroid-induced glaucoma: epidemiology, pathophysiology, and clinical management","volume":"65","author":"Roberti","year":"2020","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111041_bib33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","article-title":"Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces","volume":"28","author":"Rubtsov","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.exer.2026.111041_bib34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.exer.2026.111041_bib35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2024.03.004","article-title":"Direct in vivo CAR T cell engineering","volume":"45","author":"Short","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.exer.2026.111041_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cyto.2014.12.017","article-title":"The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU)","volume":"74","author":"Sun","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.exer.2026.111041_bib37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2567.2006.02321.x","article-title":"Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells","volume":"117","author":"Taylor","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.exer.2026.111041_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cyto.2017.02.023","article-title":"Intravitreal injection of anti-Interleukin (IL)-6 antibody attenuates experimental autoimmune uveitis in mice","volume":"96","author":"Tode","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.exer.2026.111041_bib39","article-title":"Newly found peacekeeper: potential of CD8+ tregs for graft-versus-host disease","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2026.111041_bib40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41423-020-00615-2","article-title":"A novel CD4+ CTL subtype characterized by chemotaxis and inflammation is involved in the pathogenesis of graves' orbitopathy","volume":"18","author":"Wang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.exer.2026.111041_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70021","article-title":"Ocular immune-related diseases: molecular mechanisms and therapy","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.exer.2026.111041_bib42","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S2213-8587(25)00066-X","article-title":"Thyroid eye disease (graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management","volume":"13","author":"Wiersinga","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.exer.2026.111041_bib43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.exer.2026.111041_bib44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nm1365","article-title":"Effective gene therapy with nonintegrating lentiviral vectors","volume":"12","author":"Y\u00e1\u00f1ez-Mu\u00f1oz","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2026.111041_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aeb3991","article-title":"Apolipoprotein E drives microglia activation in the development of autoimmune uveitis through up-regulation of peptidyl prolyl isomerase F","volume":"12","author":"Zeng","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.exer.2026.111041_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160377","article-title":"Rapamycin improves graves' orbitopathy by suppressing CD4+ cytotoxic T lymphocytes","volume":"8","author":"Zhang","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.exer.2026.111041_bib47","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1089\/thy.2020.0088","article-title":"A promising mouse model of graves' orbitopathy induced by adenovirus expressing thyrotropin receptor A subunit","volume":"31","author":"Zhang","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.exer.2026.111041_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100866","article-title":"Activation of the interleukin-23\/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis","volume":"80","author":"Zhong","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2026.111041_bib49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cell.2025.11.035","article-title":"Next steps in regulatory T cells: biology and clinical application","volume":"189","author":"Zou","year":"2026","journal-title":"Cell"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526001971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526001971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:42:55Z","timestamp":1793943775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526001971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"alternative-id":["S0014483526001971"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.111041","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo engineering of immunosuppressive T cells to treat ocular autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.111041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111041"}}